Effects of low - dose aspirin on clinic and ambulatory blood pressure <font color="red">in_1</font> <font color="red">treated_4</font> <font color="red">hypertensive_4</font> <font color="red">patients_4</font> <font color="red">._4</font> Collaborative Group of the Primary Prevention Project ( PPP)--Hypertension study . 
<br>
<br> <font color="red">Nonsteroidal_1</font> <font color="red">antiinflammatory_1</font> <font color="red">drugs_1</font> <font color="red">may_1</font> <font color="red">affect_1</font> <font color="red">blood_1</font> <font color="red">pressure_1</font> <font color="red">(_1</font> <font color="red">BP_1</font> <font color="red">)_1</font> <font color="red">control_1</font> <font color="red">in_1</font> <font color="red">hypertensive_4</font> <font color="red">patients_4</font> <font color="red">receiving_4</font> <font color="red">drug_4</font> <font color="red">treatment_4</font> <font color="red">,_4</font> but data on the effects of low - dose aspirin are scanty . This study assessed the effects of chronic treatment with low doses of aspirin ( 100 mg / day ) on clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP in <font color="red">hypertensives_1</font> <font color="red">on_1</font> <font color="red">chronic_1</font> <font color="red">,_1</font> <font color="red">stable_1</font> <font color="red">antihypertensive_1</font> <font color="red">therapy_1</font> <font color="red">._1</font> The study was conducted in the framework of the Primary Prevention Project ( PPP ) , a randomized , controlled factorial trial on <font color="red">the_1</font> <font color="red">preventive_1</font> <font color="red">effect_1</font> <font color="red">of_1</font> <font color="red">aspirin_1</font> <font color="red">or_1</font> <font color="red">vitamin_1</font> <font color="red">E_1</font> <font color="red">in_1</font> <font color="red">people_2</font> <font color="red">with_2</font> <font color="red">one_2</font> <font color="red">or_2</font> <font color="red">more_2</font> <font color="red">cardiovascular_2</font> <font color="red">risk_2</font> <font color="red">factors_2</font> <font color="red">._2</font> <font color="red">Fifteen_4</font> <font color="red">Italian_5</font> <font color="red">hypertension_4</font> <font color="red">units_4</font> <font color="red">studied_4</font> <font color="red">142_7</font> <font color="red">hypertensive_7</font> <font color="red">patients_7</font> <font color="red">(_7</font> <font color="red">76_7</font> <font color="red">men_7</font> <font color="red">,_7</font> <font color="red">66_7</font> <font color="red">women_7</font> <font color="red">;_7</font> <font color="red">mean_7</font> <font color="red">age_7</font> <font color="red">59_7</font> <font color="red">+_7</font> <font color="red">/-_7</font> <font color="red">5.9_7</font> <font color="red">years_7</font> <font color="red">)_7</font> <font color="red">treated_4</font> <font color="red">with_4</font> <font color="red">different_4</font> <font color="red">antihypertensive_4</font> <font color="red">drugs_4</font> <font color="red">:_4</font> <font color="red">71_2</font> <font color="red">patients_2</font> <font color="red">were_2</font> <font color="red">randomized_2</font> <font color="red">to_2</font> <font color="red">aspirin_2</font> <font color="red">and_2</font> <font color="red">71_2</font> <font color="red">served_2</font> <font color="red">as_2</font> <font color="red">controls_2</font> <font color="red">._2</font> <font color="red">All_2</font> <font color="red">patients_2</font> <font color="red">underwent_2</font> <font color="red">a_2</font> <font color="red">clinic_2</font> <font color="red">BP_2</font> <font color="red">evaluation_2</font> <font color="red">with_1</font> <font color="red">an_1</font> <font color="red">automatic_1</font> <font color="red">sphygmomanometer_1</font> <font color="red">and_1</font> <font color="red">a_1</font> <font color="red">24-h_1</font> <font color="red">ambulatory_1</font> <font color="red">BP_1</font> <font color="red">monitoring_1</font> <font color="red">,_1</font> <font color="red">at_1</font> <font color="red">baseline_1</font> <font color="red">and_1</font> <font color="red">after_1</font> <font color="red">3_1</font> <font color="red">months_1</font> <font color="red">of_1</font> <font color="red">aspirin_1</font> <font color="red">treatment_1</font> <font color="red">._1</font> At the end of the study the changes in clinic SBP and DBP were not statistically different in treated and untreated subjects . Ambulatory SBP and DBP after 3 months of aspirin treatment were similar to baseline : deltaSBP -0.5 mmHg ( 95% confidence intervals [ CI ] from -1.9 to + 2.9 mm Hg ) and deltaDBP -1.1 mm Hg ( 95% CI from -2.5 to + 0.3 mm Hg ) . The pattern was similar in the control group . No interaction was found between aspirin and the most used antihypertensive drug classes ( angiotensin converting enzyme inhibitors and calcium antagonists ) . Despite the relatively small sample size our results seem to exclude any significant influence of low - dose aspirin on BP control in <font color="red">hypertensives_1</font> <font color="red">under_1</font> <font color="red">treatment_1</font> <font color="red">._1</font>